CClinicalTrials.gg
CompletedNCT03832231Elasto-ICUUpdated Mar 1, 2021

Use of Transient Elastogaphy to Assess Diaphragm Function in Mechanically Ventilated Patients

An interventional study of Shear Wave Elastography in Ventilator Weaning and Intensive Care Unit, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-03-01.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Mechanical ventilation is a life-saving treatment that can be associated with diaphragm dysfunction, a potentially deleterious acquired disability. It may be the consequence of disuse - under mechanical ventilation, respiratory muscles are unloaded - or the consequence of muscle overuse because of insufficient unloading. Evaluating diaphragm function is therefore crucial to optimally tailor the ventilator assistance. Measurement of transdiaphragmatic pressure (Pdi) is the reference method to assess diaphragm function but it invasiveness hinders the generalization of its use. Previous studies have reported that ultrasound can quantify diaphragm thickening and that diaphragm thickening fraction (TFdi) is a good marker of diaphragm function. Since diaphragm becomes stiffer when it contracts, the investigators aim at exploring whether the measurement of diaphragm stiffness by transient shear wave elastography would improve the evaluation of diaphragm function with ultrasound.

Therefore, the objectives of the study are to evaluate the performance of transient shear wave elastography applied to the diaphragm to estimate Pdi in mechanically ventilated patients as compared to TFdi and to correlate the changes in elastography derived indices, in TFdi and in Pdi into different ventilatory conditions and during a spontaneous breathing trial. Pdi will be obtained using catheters positioned in patients' stomachs and esophagus and diaphragm stiffness will be assessed by measuring the shear modulus of the diaphragm with a dedicated ultrasound machine (Aixplorer, Ultrasonic). TFdi will be also measured as previously reported. Pdi, TFdi and shear modulus will be measured at the end of each four following 10 minutes-conditions: 1) baseline with initial ventilator settings (set by the physician in charge of patient); 2) 25%-increase in pressure support and initial PEEP; 3) 25%-decrease in pressure support and initial PEEP and 4) initial level of pressure support and ZEEP. Finally, the same measurements will be done at the beginning of a 30 minutes spontaneous breathing trial.

Read the detailed description

Objective :

The main objective is to correlate ultrasound indices (thickness, thickening, rigidity) to the measurement of transdiaphragmatic pressure in the evaluation of the diaphragmatic function of patients under mechanical ventilation.

Secondary objectives are: 1. Correlate thickening of the diaphragm with Pdi, 2. Correlate diaphragmatic thickening with diaphragmatic stiffness 3. Describe these correlations under different levels of pressure ventilatory support, 4. Describe the evolution of diaphragmatic stiffness, thickening and Pdi pressure during a ventilator liberating trial.

The primary endpoint is the measurement of Pdi. The secondary endpoints are the diaphragm thickening fraction and diaphragm stiffness.

Methods :

The Pdi will be obtained by measuring the esophageal and gastric pressures through nasogastric tube equipped with balloons. The position of each of the balloons will be checked by displaying the esophageal and gastric pressure lines. The intragastric position will be confirmed by mild abdominal compression. The oesophageal position is based on visualization of cardiac artifacts on the pressure pattern and signal deflations related to inspiratory movements. The signals of the esophageal and gastric pressures will be displayed continuously and their resultant - transdiapragmatic pressure - will be automatically calculated in real time by the software. It will also record pressure in the airways at the endotracheal tube.

Patients will be placed in half-sitting position to allow better recognition of the diaphragm. Using the ultrasound system Aixplorer® (Aix en Provence, France V9), equipped with a high resolution probe (6 MHz). The probe will be positioned at the intercostal space above the tenth rib on the right axillary line and directed perpendicular to the diaphragm (apposition zone). The measurements will be performed "offline" and the calculation of the thickening fraction will be performed in blind clinical conditions.

The diaphragmatic elastography will be determined using the same ultrasound system (Aixplorer®, Aix en Provence, France V9, provided with a high resolution probe (SL10-2, central frequency, 6 MHz)). The anatomical approach is the same as the intercostal approach described previously. After finding the diaphragm in B mode, a transition to SWE (elastography) mode will be performed. Three successive measurements will be made on the same region of interest, the average of the three measurements will be retained. The variation of the shear modulus during the inspiratory time will also be calculated post hoc. As for standard ultrasound, records analysis will be performed in blind conditions.

Pdi, ultrasound derived indices and shear wave modulus will be measured under several conditions.

  1. At baseline: initial ventilator settings set by the physician in charge of patient
  2. 25%-increase in pressure support and initial PEEP during 10 minutes
  3. 25%-decrease in pressure support and initial PEEP during 10 minutes
  4. initial level of pressure support without PEEP (PEEP = 0) during 10 minutes
  5. Measurement of the maximal inspiratory pressure during an inspiratory occlusion maneuver lasting 20 seconds.
  6. A 30 minutes Ventilator liberating trial without PEEP nor Pressure Support (CPAP=0)
02

Conditions studied

  • Ventilator Weaning
  • Intensive Care Unit

Keywords

  • Shear wave elastography
  • Ultrasonography
  • Transdiaphragmatic pressure
  • Diaphragmatic function
  • Mechanical ventilation
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

All patients receiving mechanical ventilation and having spontaneous efforts will be eligible if they meet the following criteria:

Inclusion criteria

Inclusion criteria

  • Age ≥ 18 years old
  • Intubation and mechanical ventilation since 24 hours
  • Failure to a first ventilator liberating trial
  • nasogastric feeding tube in place
  • readiness criteria to undertake a ventilator liberating trial (Boles et al. ERJ 2007)
  • patient written consent or next of kin written consent in case of physical inability of the patient to sign the consent form
  • french social Health Service registration

Exclusion criteria

Exclusion criteria

  • pregnancy
  • protective administrative control
  • patient's refusal
  • contra indications to the insertion of esophageal and gastric balloons
  • allergy to topical anesthetic
  • impossible weaning (full dependance to mechanical ventilation)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Ventilator liberating trial

    The diaphragmatic function of patients undergoing a ventilator liberating trial will be determined with transient shear wave elastography.

    Device: Shear Wave Elastography

Interventions

  • DeviceShear Wave Elastography

    Ultrasound technology to assess tissue stiffness

06

What researchers measure

Primary outcomes

  1. Change in transdiaphragmatic pressure

    Reference method to assess diaphragm function computed as the difference between esophageal pressure and gastric pressure

    Time frame: Through patient participation, an average of 1 day

Secondary outcomes

  1. Change in diaphragm thickness and thickening as expressed by the thickening fraction (ratio of the difference between inspiratory and expiratory thickness over expiratory thickness).

    Using the ultrasound system Aixplorer® (Aix en Provence, France V9), equipped with a high resolution probe (6 MHz), anatomical structures will be identify using B-mode. A switch to TM-mode will allow us to measure the thickening fraction. A second switch to shear wave elastography allows to identify an elastography map of the diaphragm and calculate an average of the shear wave modulus.

    Time frame: Through patient participation, an average of 1 day

  2. Change in diaphragm stiffness

    Using the ultrasound system Aixplorer® (Aix en Provence, France V9), equipped with a high resolution probe (6 MHz), anatomical structures will be identify using B-mode. A switch to TM-mode will allow us to measure the thickening fraction. A second switch to shear wave elastography allows to identify an elastography map of the diaphragm and calculate an average of the shear wave modulus.

    Time frame: Through patient participation, an average of 1 day

  3. Success or failure at the spontaneous breathing trial

    Presence of clinical intolerance criteria according to Boles et al. ERJ 20107

    Time frame: Through patient participation, an average of 1 day

07

Study locations

1 site
  • Groupe Hospitalier Pitié-Salpétrière
    Paris, 75013, France
08

References and documents

Publications

  • Fosse Q, Poulard T, Nierat MC, Virolle S, Morawiec E, Hogrel JY, Similowski T, Demoule A, Gennisson JL, Bachasson D, Dres M. Ultrasound shear wave elastography for assessing diaphragm function in mechanically ventilated patients: a breath-by-breath analysis. Crit Care. 2020 Nov 27;24(1):669. doi: 10.1186/s13054-020-03338-y. PubMed 33246478 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03832231
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Feb 6, 2019
Start date
Feb 14, 2019
Primary completion
Feb 15, 2019
Completion
Jul 9, 2020
Last update
Mar 1, 2021

Study contacts

Martin DRES, MD, PhD
principal investigator · Assistance Publique Hoptiaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion